Seminar at The Houstonian has been Postponed
We have been closely monitoring the guidelines set forth from the Centers for Disease Control (CDC) and the World Health Organization (WHO) in response to COVID-19. The safety and health of our team, clients and community is extremely important to us and because of this, we have decided to postpone our seminar at The Houstonian on March 19th.
If you have RSVP’d for this seminar, you will be contacted by a Client Service Coordinator with details on how to access our upcoming webinar.
If you were interested in attending but had not RSVP’d, we encourage you to contact our Client Services Department at firstname.lastname@example.org or sign up to be notified when a new date has been scheduled.
We thank you for your patience during this critical time and as a leader in regenerative medicine, we want to assure you that we are working diligently to do our part in this rapidly evolving situation.
More Recent News
Celltex Therapeutics Receives Another FDA Approval: Phase II Clinical Trial Using Mesenchymal Stem Cells (MSCs) as a Prophylactic Against COVID-19Read More
Rick Perry Discusses Celltex’s COVID-19 Clinical Trials on Fox News TV
Former U.S. Secretary of Energy and former Governor of Texas, Rick Perry, was on Fox News TV discussing Celltex’s COVID-19 ongoing clinical trials and the ingenuity that will deliver a victory over this virus.Read More